Listed

Kraig Biocraft Laboratories, Inc.: Form 10-Q for the period ended Jun 30, 2014

Filed with the SEC on Aug 14, 2014 and accepted by EDGAR at Aug 14, 2014, 17:01 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2014-04-01 to 2014-06-30$108.1kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2014-01-01 to 2014-06-30$224.1kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2014-04-01 to 2014-06-30−$545.7kus-gaap:OperatingIncomeLoss
Operating income6 months2014-01-01 to 2014-06-30−$1.2mus-gaap:OperatingIncomeLoss
Interest expense3 months2014-04-01 to 2014-06-30$18.3kus-gaap:InterestExpense
Interest expense6 months2014-01-01 to 2014-06-30$35.3kus-gaap:InterestExpense
Net income3 months2014-04-01 to 2014-06-30−$564.0kus-gaap:NetIncomeLoss
Net income6 months2014-01-01 to 2014-06-30−$1.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2014-04-01 to 2014-06-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2014-01-01 to 2014-06-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2014-01-01 to 2014-06-30−$500.4kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2014-06-30$543.2kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-06-30$544.9kus-gaap:AssetsCurrent
Total assetsAt period end2014-06-30$555.9kus-gaap:Assets
Current liabilitiesAt period end2014-06-30$1.5mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2014-06-30−$976.6kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001354488-14-004265. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.